Stockreport

DBV Technologies: Uncertainty Still Exists Despite Recent 90% Rally [Seeking Alpha]

DBV Technologies S.A. - American Depositary Shares  (DBVT) 
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF Viaskin Peanut, DBVT's lead asset, is being evaluated in two Phase 3 trials targeting peanut allergies. The company's balance sheet is in good stead with a recent cap [Read more]